Financials

  • Market Capitalization 289.77 M
  • Employee 28
  • Founded 2018
  • CEO N/A
  • Website www.opusgtx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BT34Q3
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.51
Relación precio/flujo de caja
8.81

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3356
NMRA
Neumora Therapeutics, Inc. - Common Stock
1.59 USD-0.63%-8.09%+70.97%+23.26%294.60 M USD
3361
INDP
Indaptus Therapeutics, Inc. - Common Stock
2.60 USD-1.14%-2.62%-28.18%+36.84%294.43 M USD
3388
TTRX
Turn Therapeutics Inc. - Common Stock
9.59 USD+1.27%-1.24%+55.18%-4.10%285.67 M USD
3389
MGNX
MacroGenics, Inc. - Common Stock
4.30 USD-4.44%-9.47%+8.59%+173.89%273.32 M USD